Previous Article | Next Article ![]()
Infection and Immunity, October 2000, p. 5663-5667, Vol. 68, No. 10
Vanderbilt University School of Medicine and
VA Medical Center, Nashville, Tennessee1;
Department of Biochemistry and Molecular Biology, Medical
College of Georgia, Augusta, Georgia4; and
Department of Farm Animal and Equine Medicine and Surgery,
Royal Veterinary College, Potters Bar,
Hertfordshire,2 and Veterinary
Laboratories Agency (Weybridge), New Haw,
Surrey,3 United Kingdom
Received 3 April 2000/Returned for modification 27 May
2000/Accepted 4 July 2000
Phase variation of Campylobacter fetus surface
layer proteins (SLPs) occurs by inversion of a 6.2-kb DNA segment
containing the unique sap promoter, permitting expression
of a single SLP-encoding gene. Previous work has shown that the
C. fetus sap inversion system is RecA dependent. When we
challenged a pregnant ewe with a recA mutant of wild-type
C. fetus (strain 97-211) that expressed the 97-kDa SLP, 15 of the 16 ovine-passaged isolates expressed the 97-kDa protein.
However, one strain (97-209) expressed a 127-kDa SLP, suggesting
that chromosomal rearrangement may have occurred to enable SLP
switching. Lack of RecA function in strains 97-211 and 97-209 was
confirmed by their sensitivity to the DNA-damaging agent methyl
methanesulfonate. Southern hybridization and PCR of these strains
indicated that the aphA insertion into recA was stably present. However, Southern hybridizations demonstrated that in
strain 97-209 inversion had occurred in the sap locus. PCR
data confirmed inversion of the 6.2-kb DNA element and indicated that
in these recA mutants the sap inversion
frequency is reduced by 2 to 3 log10 units compared to that
in the wild type. Thus, although the major sap inversion
pathway in C. fetus is RecA dependent, alternative
lower-frequency, RecA-independent inversion mechanisms exist.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Campylobacter fetus sap Inversion Occurs
in the Absence of RecA Function
*
Corresponding author. Mailing address: Department of
Medicine, New York University Medical Center, 550 First Ave., New York, NY 10016. Phone: (212) 263-6394. Fax: (212) 263-7700. E-mail: martin.blaser{at}med.nyu.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»